BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Acthar on Proteinuria in IgA Nephropathy Patients
- First Posted Date
- 2015-03-06
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT02382523
- Locations
- 🇺🇸
Harris Health System Smith Clinic or Ben Taub Hospital, Houston, Texas, United States
HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
Phase 1
Active, not recruiting
- Conditions
- Human Papillomavirus Positive Oropharyngeal CarcinomaHuman Papillomavirus Positive Cervical CarcinomaHuman Papillomavirus Positive Anal CarcinomaHuman Papillomavirus Positive Vulvar CarcinomaHuman Papillomavirus-Related CarcinomaHuman Papillomavirus Positive Penile Carcinoma
- Interventions
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 32
- Registration Number
- NCT02379520
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Aggression Prevention Training for Caregivers of Persons With Dementia (APT)
Not Applicable
Completed
- Conditions
- AggressionInterpersonal RelationsPainAlzheimer's DiseaseDementiaDepression
- Interventions
- Behavioral: Aggression Prevention Training (APT)Other: Enhanced Usual Primary Care (EU-PC)
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2020-12-11
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 239
- Registration Number
- NCT02380703
Use Of Oral Fidaxomicin Vs. Oral Vancomycin For Clostridium Difficile Infection In Patients With Spinal Cord Injury
Phase 4
Terminated
- Conditions
- Clostridium DifficileSpinal Cord Injury
- Interventions
- First Posted Date
- 2015-02-04
- Last Posted Date
- 2016-10-13
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 12
- Registration Number
- NCT02355938
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
A Comparison of UGBRS Block and Local Infiltration
Phase 4
Completed
- Conditions
- Appendicitis
- Interventions
- Procedure: UGBRSBProcedure: Local Infiltration
- First Posted Date
- 2015-02-02
- Last Posted Date
- 2015-07-21
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 50
- Registration Number
- NCT02352519
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Glutathione and Function in HIV Patients
Phase 1
Completed
- Conditions
- HIV InfectionErythrocyte Glutathione Deficiency
- Interventions
- Dietary Supplement: GlyNAC (combination of glycine and n-acetylcysteine)
- First Posted Date
- 2015-01-28
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 16
- Registration Number
- NCT02348775
- Locations
- 🇺🇸
Baylor Metabolic Research Unit (MRU), Houston, Texas, United States
Lifestyle Intervention for Senior Diabetics
Not Applicable
Completed
- Conditions
- OverweightAgingDiabetes Mellitus
- Interventions
- Behavioral: Healthy lifestyleBehavioral: Weight loss and Exercise
- First Posted Date
- 2015-01-28
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 100
- Registration Number
- NCT02348801
- Locations
- 🇺🇸
Michael E DeBakey VA Medical Center, Houston, Texas, United States
Energetics and Function in Older Humans
Phase 1
Completed
- Conditions
- AgingErythrocyte Glutathione DeficiencyMuscle Weakness
- Interventions
- Dietary Supplement: Cysteine (as n-acetylcysteine) and Glycine
- First Posted Date
- 2015-01-28
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 16
- Registration Number
- NCT02348762
- Locations
- 🇺🇸
Baylor Metabolic Research Unit (MRU), Houston, Texas, United States
Treatment of Hemoglobin SC Disease With Hydroxyurea
- First Posted Date
- 2015-01-13
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 32
- Registration Number
- NCT02336373
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children
Phase 1
Completed
- Conditions
- Hematogenously Acquired Staphylococcus Aureus OsteomyelitisBone InfectionOsteomyelitis
- Interventions
- First Posted Date
- 2015-01-12
- Last Posted Date
- 2021-11-02
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 11
- Registration Number
- NCT02335905
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath